Daniel J. Brennan serves as the Executive Vice President and Chief Financial Officer at Boston Scientific Corporation, a leading innovator of medical solutions that improve the health of patients around the world. In his role, Brennan is responsible for overseeing the company's global financial strategy, which includes financial planning and analysis, accounting, tax, treasury, and investor relations. His leadership has been instrumental in driving Boston Scientific's financial performance and growth, contributing to the company's success in delivering life-enhancing medical technologies. Prior to joining Boston Scientific in 2014, Brennan held various senior financial positions at several prominent companies. He spent over a decade at Covidien, where he ultimately served as Vice President of Finance for the company's $7 billion Medical Devices segment. Before Covidien, Brennan worked at Tyco International and started his career at Price Waterhouse. His extensive experience in the medical device industry and strong financial acumen have been key assets in his role at Boston Scientific. Brennan holds a Bachelor of Science degree in Accounting from Villanova University and is a Certified Public Accountant. Under Brennan's financial leadership, Boston Scientific has achieved significant milestones, including the successful acquisition and integration of several key companies, such as BTG plc and Preventice Solutions. These strategic moves have expanded the company's portfolio and strengthened its position in the global medical technology market. Brennan's commitment to driving operational excellence and fostering a culture of innovation has been vital to Boston Scientific's continued success and its mission to transform patient lives through groundbreaking medical solutions.